William J. Chase

Companies

• GRAILBoard member Jun 11, 2024 to now¹
• Intellia TherapeuticsBoard member Apr 18, 2023 to now²
• AbbVieEVP, Finance & Administration Dec 14, 2018 to Jun 28, 2019³
• AbbVieChief financial officer Dec 7, 2012 to Mar 2, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GRAIL GRAL42,978 shares⁵$5.8M at $135.46Jul 15, 2026
• Intellia Therapeutics NTLA143,893 shares⁶$1.6M at $11.34Jun 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Granted 276 shares at $74.36 of GRAIL⁵
• Jun 18, 2026Granted 5,491 shares at $63.74 of GRAIL⁷
• Jun 9, 2026Granted 9,200 shares of Intellia Therapeutics⁶
• Apr 15, 2026Granted 408 shares at $49.79 of GRAIL⁸
• Jan 15, 2026Granted 213 shares at $97.44 of GRAIL⁹
• Oct 15, 2025Granted 275 shares at $75.52 of GRAIL¹⁰
• Aug 20, 2025Bought 100,000 shares at $10.03 of Intellia Therapeutics¹¹
• Jul 15, 2025Granted 533 shares at $38.53 of GRAIL¹²
• Jun 11, 2025Granted 8,000 shares of Intellia Therapeutics¹³
• May 29, 2025Granted 6,082 shares at $41.10 of GRAIL¹⁴
• Apr 15, 2025Granted 784 shares at $25.94 of GRAIL¹⁵
• Jan 15, 2025Granted 1,182 shares at $17.58 of GRAIL¹⁶
• Oct 30, 2024Granted 210 shares at $13.62 of GRAIL¹⁷
• Oct 15, 2024Granted 1,054 shares at $14.01 of GRAIL¹⁸
• Jun 25, 2024Granted 26,470 shares of GRAIL¹⁹
• Jun 12, 2024Granted 7,737 shares of Intellia Therapeutics²⁰
• Jun 14, 2023Granted 1,673 shares of Intellia Therapeutics²¹
• Apr 14, 2023Granted 10,483 shares of Intellia Therapeutics²²